Please login to the form below

Not currently logged in
Email:
Password:

Lucid wins Queen’s Award for business success

Accolade comes shortly after the agency celebrated its ten-year anniversary

The Queen's AwardLucid Group has received a Queen’s Award for Enterprise in International Trade, with the accolade arriving shortly after the Buckinghamshire, UK-based agency celebrated its ten-year anniversary.

The prestigious trade award can only go to firms that manage to avoid any ‘slumps’ or ‘dips’ over three ‘outstanding’ years or six ‘continuous’ years.

Jan Steele, Lucid’s Co-founder and COO, said: “Winning a Queen’s Award for Enterprise is a tremendous honour for everyone who has contributed to our success.

“Our shared passion and vision to improve patient outcomes via behaviour change and strategic communication programmes is unrelenting and is the key to our winning formula.

“To be granted such a prestigious award in a category where were competing with very diverse businesses makes us very proud.”

Lucid’s strategy sees its operations split into two divisions, with a US office pulling in 66% of its oversees sales and a UK base that covers the rest of the world.

The firm's Queen’s Award is the latest in a line of prizes for the agency that include Medical Education Consultancy of the year at Communiqué’s 2015 awards - the third consecutive year of winning that prize - and Support Agency of the Year at last year’s PMEA.

Article by
Gemma Jones

26th April 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics